Prevalence of tumour-infiltrating CD103+ cells identifies therapeutic-sensitive prostate cancer with poor clinical outcome (vol 128, pg 1466, 2023)
BRITISH JOURNAL OF CANCER(2023)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
BRITISH JOURNAL OF CANCER(2023)